Amanat Acquisition Corp AMAN
10.14 USD +0.03 (+0.30%)
At closeNov 4, 2026, 4:00 PM EST
10.19 +0.05 +0.45%
After hours · Nov 4, 4:00 PM ET
10.11 Day range 10.17
9.98 52-week range 10.79
- YTD
- +1.30%
- 1 year
- +1.30%
- Market cap
- 98.10M
- YTD return
- +1.30%
- 1-year return
- +1.30%
- Volume
- 78.44K
- Avg volume
- 50.58K
- Open
- 10.12
- Previous close
- 10.11
- Day's range
- 10.11 – 10.17
- 52-week range
- 9.98 – 10.79
YTD +0.14 (+1.40%)
Financials — quick view
AMAN Revenue — quarterly 0
AMAN Net income — quarterly 31.73K
AMAN EPS — quarterly 0.01
News
Amanat Acquisition To Merge With Corxel Pharmaceuticals; Transaction Includes Concurrent, Oversubscribed PIPE With Expected Gross Proceeds Of ~$300M In Addition To ~$75M In Amanat’s Trust Account 
Corxel US and Amanat Acquisition Corp Announce Definitive Business Combination Agreement to Create Publicly Listed Obesity-Focused Biopharmaceutical Company 
Amanat Acquisition Corp. (NASDAQ:AMAN) Shares Shorted: Short Interest Down 50.6% in September 
Amanat Acquisition Corp Prices $75M IPO Of 7.5M Shares At A Price Of $10/Share To Trade On Nasdaq Under Ticker "AMAN" 
This Analyst With 83% Accuracy Rate Sees Over 35% Upside In Amazon.com - Here Are 5 Stock Picks For Q3 From Wall Street's Most Accurate Analysts
Your note
Sign in to keep a note on AMAN — it syncs with the Stock Master app.